Amicus Therapeutics CEO John Crowley
Goldman Sachs Talks
Introduction
John Crowley's involvement with biotechnology started in 19 98. Two of his children were diagnosed with pompey disease, a rare and often fatal disorder. He left his roll at bristol mire squib to join and found novazim therapeutics. Since two thousand and five he's been chairman and co of amichus Therapeutics.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
